A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
for Chronic Myeloid Leukemia
4 locations incl. New York
Sponsor: Enliven Therapeutics
Sex: All·Age: 18+
Code: NCT05304377·Phase 1·Recruiting·Listed Mar 2022
Knight Cardiovascular Institute
Clinical research site in Portland, Oregon · 2222 NW LOVEJOY ST, #606, PORTLAND, OR 97210-3033 · (503) 229-7554 · Website
As of September 2026, 1 paid clinical trial is recruiting at Knight Cardiovascular Institute in Portland, Oregon. Active studies at this site cover conditions such as Chronic Myeloid Leukemia, Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive and Cml. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
New trial at Knight Cardiovascular Institute? We'll email you when one opens.
Recruiting clinical trials at Knight Cardiovascular Institute (1)
Get new-trial alerts for Knight Cardiovascular Institute
We'll email you whenever a new clinical trial starts recruiting at this research site in Portland, OR. Unsubscribe anytime.
More research sites in Portland
- Oregon Health and Science University (195 trials)
- Oregon Health & Science University (166 trials)
- Providence Portland Medical Center (117 trials)
- Providence Saint Vincent Medical Center (90 trials)
- OHSU Knight Cancer Institute (46 trials)
- Providence St. Vincent Medical Center (26 trials)
- VA Portland Health Care System, Portland, OR (26 trials)
- Oregon Health Sciences University (21 trials)
- Oregon Health & Science University (OHSU) (19 trials)
- Legacy Emanuel Children's Hospital (18 trials)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in Portland, OR · Oregon clinical trials